AGTECH HOLDINGS(08279)
Search documents
亚博科技控股(08279) - 股份发行人的证券变动月报表(截至2025年12月31日)
2026-01-05 10:00
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 亞博科技控股有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08279 | 說明 | | | | | | | | | 已發行股份(不包括庫存股份)數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 11,672,342,235 | | 0 | | 11,672,342,235 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 11,672,342,235 | | 0 | | 11,672,342,235 | 第 2 頁 共 10 頁 v 1.1.1 III.已發 ...
港股午评:恒指跌0.92%、科指跌1.79%,保险股走高,科网股、生物医药及芯片股走低
Jin Rong Jie· 2025-12-15 04:14
Market Overview - The Hong Kong stock market experienced fluctuations and adjustments, with the Hang Seng Index down 0.92% to 25,737.85 points, the Hang Seng Tech Index down 1.79% to 5,537.11 points, the National Enterprises Index down 1.2% to 8,970.29 points, and the Red Chip Index down 0.3% to 4,137.97 points due to the significant drop in US stocks last Friday [1] - Major technology stocks saw declines, with Alibaba down 2.73%, Tencent Holdings down 1.54%, JD Group down 1.12%, Xiaomi down 2.28%, NetEase down 0.18%, Meituan down 1.07%, Kuaishou down 3.85%, and Bilibili down 1.12% [1] - Insurance stocks performed well, with China Ping An reaching a four-year high, while the biopharmaceutical sector weakened, with Baijiazhensheng down over 6% [1] - Semiconductor stocks faced significant declines, with Huahong Semiconductor down over 6% [1] Company News - China Merchants Energy (01138.HK) signed shipbuilding contracts with Dalian China Merchants Heavy Industry, Yangzhou China Merchants Heavy Industry, and Guangdong China Merchants Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported a cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [4] - Yida China (03639.HK) reported a contract sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [5] - Kason International (00496.HK) signed a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [5] Clinical and Regulatory Updates - Boke Vision Cloud-B (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Fuhong Hanlin (02696.HK) received acceptance from the National Medical Products Administration for the listing registration application of Hanshuo® in combination with chemotherapy for neoadjuvant/adjuvant treatment of gastric cancer, which has been included in priority review [6] - Shijiazhuang Pharmaceutical Group (01093.HK) received approval for a new indication for Donyi® (liposomal irinotecan injection) for first-line treatment in patients with metastatic pancreatic cancer [6] - Hengrui Medicine (01276) received a clinical trial approval notice for HRS-1780 tablets [8] Investment Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong stock market opens up space for a market rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - Dongwu Securities highlighted that the main focus for Hong Kong stocks is on technology and cyclical sectors, while also paying attention to innovative drugs, suggesting a barbell allocation strategy due to potential macro and political risks [13] - CITIC Securities projected that the Hong Kong stock market will benefit from internal "14th Five-Year Plan" catalysts and external fiscal and monetary easing from major economies, expecting a sustainable upward trend in revenue and profit [13] - Dongwu Securities also forecasted a continued recovery in the Hong Kong stock market in 2026, citing expected interest rate cuts by the Federal Reserve and a temporary easing of Sino-US relations [14]
港股开盘:恒指跌1%、科指跌1.34%,三胎概念及光伏股走高,科网股、创新药概念股普跌
Sou Hu Cai Jing· 2025-12-15 01:37
Market Overview - The Hong Kong stock market opened lower on December 15, with the Hang Seng Index down 1% at 25,718.14 points, the Hang Seng Tech Index down 1.34% at 5,562.67 points, and the State-Owned Enterprises Index down 1.09% at 8,980.13 points [1] - Major tech stocks declined, including Alibaba down 2.14%, Tencent down 1.62%, and JD.com down 0.61% [1] - The innovative drug sector saw several stocks open lower, with Genscript Biotech down 5.92% and Zai Lab down 3.48% [1] - Chinese brokerage stocks collectively fell, with Everbright Securities dropping over 1% [1] - The automotive sector also experienced declines, with Li Auto down over 2% and XPeng down nearly 2% [1] - However, three-child policy concept stocks and photovoltaic stocks mostly rose, with star stock Jinxin Fertility rising about 3% [1] Company News - China Merchants Energy (01138.HK) signed shipbuilding contracts for one ethylene ship and eighteen oil tankers, totaling RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, a year-on-year increase of 24.63% [4] - Yida China (03639.HK) reported contract sales amounting to approximately RMB 681 million in the first eleven months, a year-on-year decrease of 23.22% [5] - Bole Technology (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Junshi Biosciences (02696.HK) received acceptance for its marketing application for Hansizhuang® in combination with chemotherapy for gastric cancer [6] - CSPC Pharmaceutical Group (01093.HK) received approval for a new indication for its drug, Donyin® (liposomal irinotecan injection), for first-line treatment in metastatic pancreatic cancer patients [6] - Biyuan (00926.HK) increased its investment in ERX to maintain a 3% stake to support innovative research and development of non-GLP-1 weight loss therapies [7] - Hengrui Medicine (01276) received approval for clinical trials for HRS-1780 tablets [8] - AVIC Industry (02357.HK) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [9] - China Environmental Resources (01130.HK) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [10] - AVIC Industry (02357.HK) proposed to implement full circulation of H-shares [11] - Yabo Technology Holdings (08279.HK) signed a framework agreement with Alipay (Hangzhou) [12] Institutional Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong stock market opens up space for a market rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - CITIC Securities noted strong performance in gold and silver, while other risk assets were weak, predicting a segmented market for precious metals in 2025 [13] - CITIC Securities also emphasized the importance of resource self-sufficiency in the lithium industry, highlighting the need for low-cost quality resources to navigate market cycles [14]
中远海能签订近80亿元造船合同 富力地产前11月销售额同比增超两成
Xin Lang Cai Jing· 2025-12-12 12:42
Company News - China COSCO Shipping Energy Transportation Co., Ltd. (中远海能) has signed shipbuilding contracts with Dalian COSCO Shipping Heavy Industry, Yangzhou COSCO Shipping Heavy Industry, and Guangdong COSCO Shipping Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [1] - ZhongAn Online P&C Insurance Co., Ltd. (众安在线) reported a total original insurance premium income of approximately RMB 32.904 billion for the first eleven months [2] - R&F Properties Co., Ltd. (富力地产) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [3] - Yida China Holdings Limited (亿达中国) reported a contracted sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [4] - Karsen International Holdings Limited (卡森国际) has entered into a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [4] Clinical and Regulatory Updates - Bolex Cloud-B (拨康视云-B) successfully held a meeting after the second phase of clinical trials for CBT-004 [5] - Innovent Biologics, Inc. (复宏汉霖) has had its application for the marketing registration of Hansizhuang® combined chemotherapy for gastric cancer accepted by the National Medical Products Administration, and it has been included in the priority review [5] - CSPC Pharmaceutical Group Limited (石药集团) received approval for a new indication for Donyi® (Irinotecan Liposome Injection) for first-line treatment in patients with metastatic pancreatic cancer [5] - Heng Rui Medicine (恒瑞医药) received a clinical trial approval notice for HRS-1780 tablets [7] Investment and Acquisition Activities - AVIC Aviation Industry Corporation (中航科工) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [8] - China Environment Resources Holdings Limited (中国环境资源) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [9] - AVIC Aviation Industry Corporation (中航科工) has proposed to implement full circulation of H-shares [10] - Yabo Technology Holdings Limited (亚博科技控股) has entered into a framework agreement with Alipay (Hangzhou) [11] Financing and Buyback Activities - Yum China Holdings, Inc. (百胜中国) has entered into a share buyback agreement with a total repurchase amount of approximately USD 460 million, including about HKD 880 million under the Hong Kong plan, as part of a plan to return USD 1.5 billion to shareholders through dividends and share buybacks by 2026 [12] - Tencent Holdings Limited (腾讯控股) repurchased approximately 1.044 million shares for about HKD 636 million, with repurchase prices ranging from HKD 601.5 to HKD 616 [13] - Xuanwu Cloud (玄武云) repurchased 6,000 shares for a total of HKD 6,467.79, with prices between HKD 1.05 and HKD 1.07 [14] - China COSCO Shipping Holdings Co., Ltd. (中远海控) repurchased approximately 4.461 million shares for about HKD 60.8605 million, with prices ranging from HKD 13.38 to HKD 13.82 [15] - Geely Automobile Holdings Limited (吉利汽车) repurchased approximately 1.362 million shares for about HKD 23.9241 million, with prices between HKD 17.29 and HKD 17.82 [16] - China Anshun Energy (中国安储能源) plans to issue a total of 524 million shares at a discount of approximately 19.12%, aiming to raise about HKD 288.2 million [16]
亚博科技控股与支付宝(杭州)订立框架协议
Zhi Tong Cai Jing· 2025-12-12 11:33
亚博科技控股(08279)发布公告,于2025年12月12日,本公司与支付宝(杭州)订立框架协议,本公司与支 付宝(杭州)可不时自行或促使其各自的附属公司及/或关联公司订立具体执行协议,以提供由本集团向支 付宝(杭州)集团提供的支付宝"碰一下"服务,期限自生效日期起至2027年3月31日止。 董事会认为,该等交易将促进本集团与支付宝(杭州)集团之间的更紧密合作,并能使本集团依托支付宝 庞大的生态系统及专业技术,以加快在中国内地及澳门推出支付宝"碰一下"支付设备及采用非接触式支 付功能。支付宝"碰一下"支付设备让中国内地消费者只需轻轻触碰智能手机即可完成支付,无需扫描任 何二维码。此类设备亦支援"轻触点餐"服务。透过积极推广上述支付设备,本集团预期可从合作中获取 支付宝"碰一下"服务费收入,同时藉由采用先进的支付方案而巩固其在市场上的策略地位。董事会认 为,该合作亦将提升本集团终端用户的支付便利性,加强本集团在数字支付领域的地位,并契合市场对 高效、无缝及非接触式支付方案日益增长的需求。 ...
亚博科技控股(08279) - 修订持续关连交易的现有2025/26年度支付宝支付相关服务年度上限-...
2025-12-12 10:15
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 AGTech Holdings Limited 亞博科技控股有限公司* (於百慕達註冊成立之有限公司) (股份代號:8279) 修訂持續關連交易的 現有2025/26年度支付寶支付 相關服務年度上限- 2023年框架協議 謹此提述本公司日期為2023年12月21日的公告,內容有關本公司與服務供應商(即 支付寶、Alipay Singapore及螞蟻銀行(澳門))就於2024年1月1日起至2026年3月 31日止期間提供支付服務及相關服務而訂立2023年框架協議。 因下文「修訂現有2025/26年度支付寶支付相關服務年度上限的理由及裨益」一節 所披露的理由,董事會議決修訂並提高現有2025/26年度支付寶支付相關服務年 度上限,由低於3,000,000港元調高至經修訂2025/26年度支付寶支付相關服務年 度上限為5,000,000港元。 1 GEM上市規則的涵義 於本公告日期,本公司控股股東Ali For ...
亚博科技控股(08279)与支付宝(杭州)订立框架协议
智通财经网· 2025-12-12 10:09
智通财经APP讯,亚博科技控股(08279)发布公告,于2025年12月12日,本公司与支付宝(杭州)订立框架 协议,本公司与支付宝(杭州)可不时自行或促使其各自的附属公司及/或关联公司订立具体执行协议,以 提供由本集团向支付宝(杭州)集团提供的支付宝"碰一下"服务,期限自生效日期起至2027年3月31日 止。 董事会认为,该等交易将促进本集团与支付宝(杭州)集团之间的更紧密合作,并能使本集团依托支付宝 庞大的生态系统及专业技术,以加快在中国内地及澳门推出支付宝"碰一下"支付设备及采用非接触式支 付功能。支付宝"碰一下"支付设备让中国内地消费者只需轻轻触碰智能手机即可完成支付,无需扫描任 何二维码。此类设备亦支援"轻触点餐"服务。透过积极推广上述支付设备,本集团预期可从合作中获取 支付宝"碰一下"服务费收入,同时藉由采用先进的支付方案而巩固其在市场上的策略地位。董事会认 为,该合作亦将提升本集团终端用户的支付便利性,加强本集团在数字支付领域的地位,并契合市场对 高效、无缝及非接触式支付方案日益增长的需求。 ...
亚博科技控股(08279) - 持续关连交易 – 框架协议有关提供支付宝「碰一下」服务
2025-12-12 10:00
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 GEM上市規則之涵義 AGTech Holdings Limited 亞博科技控股有限公司* (於百慕達註冊成立之有限公司) (股份代號:8279) 持續關連交易 – 框架協議 有關 提供支付寶「碰一下」服務 框架協議 於2025年12月12日,本公司與支付寶(杭州)訂立框架協議,據此,本公司與支 付寶(杭州)可不時自行或促使其各自之附屬公司及╱或關聯公司訂立具體執行 協議,以提供由本集團向支付寶(杭州)集團提供之支付寶「碰一下」服務,期限 自生效日期起至2027年3月31日止。 於本公告日期,Ali Fortune為本公司之控股股東,其由阿里巴巴控股及Ant International (Cayman) Holding Limited分別間接擁有60%及40%權益。支付寶(杭 州)為螞蟻科技之間接全資附屬公司,而螞蟻科技約33%股權由阿里巴巴控股間 接持有。支付寶(杭州)屬於阿里巴巴控股之聯營公司,因此 ...
亚博科技控股(08279) - 致非登记持有人之通知信函及申请表格 - 刊发有关二零二五年九月三十日...
2025-12-05 11:47
(Stock Code 股份代號: 8279) (incorporated in Bermuda with limited liability) (於百慕達註冊成立之有限公司) NOTIFICATION LETTER 通知信函 December 5, 2025 Dear Non-registered Holder(s) (Note 1), AGTech Holdings Limited (the "Company") – Notification of publication of the Interim Report of the Company for the six months ended September 30, 2025 (the "Current Corporate Communication") AGTech Holdings Limited 亞博科技控股有限公司* By the order of the Board AGTech Holdings Limited Sun Ho Chairman & CEO Notes: 1. Non-Registered Holder means such ...
亚博科技控股(08279) - 致登记股东之通知信函及回条 - 刊发有关二零二五年九月三十日止六个月...
2025-12-05 11:44
AGTech Holdings Limited 亞博科技控股有限公司* (incorporated in Bermuda with limited liability) (於百慕達註冊成立之有限公司) (Stock Code 股份代號: 8279) NOTIFICATION LETTER 通知信函 December 5, 2025 Dear Registered Shareholders, AGTech Holdings Limited (the "Company") – Notice of publication of the Interim Report of the Company for the six months ended September 30, 2025 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communication are now available on the Company's website at ww ...